Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
Keyword(s):
Phase Ii
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4166-4166
◽
2008 ◽
Vol 26
(7)
◽
pp. 1178-1179
◽
Keyword(s):
2012 ◽
Vol 69
(6)
◽
pp. 1641-1645
◽